Search results
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
Investor's Business Daily· 2 years agoPharmaceutical stocks GSK, Sanofi and Haleon have wiped out a combined $31 billion in market cap...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 1 week agoMonday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE), following a Delaware judge’s ruling on 31 May that more...
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
FDA Head Questioned on Zantac’s Hidden Cancer Risk by Top Democrat DeLauro
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- The Food and Drug Administration’s chief is facing questions from a top lawmaker...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
GSK & Others Get Relief as US Court Dismisses Zantac Litigation
Zacks via Yahoo Finance· 2 years agoGSK GSK issued a statement welcoming the decision of a Multi-District Litigation (MDL) court of...
GSK attacks ‘meritless claims’ over heartburn drug Zantac
The Independent via Yahoo News· 2 years agoGSK and its consumer spin-off brand Haleon have hit back at market speculation over heartburn drug...
GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023
Benzinga via Yahoo Finance· 1 year agoThe first scheduled trial expected next week, related to GSK Plc's (NYSE: GSK) Zantac associated...
Sanofi to Settle Claims That Heartburn Drug Zantac Caused Cancer
The Wall Street Journal· 2 months agoBUSINESS Sanofi said it reached an agreement in principle to settle about 4,000 claims around...
UPDATE 3-GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link
Reuters via Yahoo Finance· 2 years agoDrugmakers GSK Plc, Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands...